Page 1Apple_logo_blackPage 1Page 1Page 1TrianglePage 1close iconPage 1Page 1Fill 1Group 3!Fill 1Icons / icon-checkicon-cvvCVVCVVicon-down-arrowicon-upicons/icon-menu-v2Icons / icon-multiplyicon-plusIcons / icon-quoteicon-up-arrowicon-upFill 6logo/logo-bluelogo-smalllogoPage 1Page 1Page 1GroupPage 1GroupFill 1Triangle 1plus-buttonPage 1Page 1Page 1Page 1Fill 4

Igniting a maternal health revolution

We are a women’s health company solving the most significant yet underserved global challenges today in maternal health. We combine connected devices with data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. At the center of our solution is a prenatal wearable that tracks critical health parameters of maternal and fetal health. By addressing modifiable risk factors, detecting abnormalities, and predicting adverse events, Bloomlife aims to ensure every family gets a healthy start.

Preterm labor contractions are extremely difficult for moms to detect. Having a monitor like Bloomlife will assist me to extend the pregnancy allowing the baby or babies to be born older, stronger, and more likely to avoid long-term complications.

John Elliott, MD, MFM, Specialist in high-order multiples

Bloomlife allows the pregnant mom to access clearly and confidently what can be confusing to some women – WHAT is happening in there? In her body she can feel it, with Bloomlife she can see it and document it.

Felicia Roche, Doula

Bloomlife helped make the final trimester journey that much smoother. I felt at peace knowing that my contractions were being tracked and I could look and see it anytime that I wanted.

Ally, 1st-Time Mom

Good data does a world of good

Over the past 18 months, we built a unique data asset in maternal health, which powers our Prenatal Atlas platform for risk stratification and biomarker discovery. Through a direct-to-mom pregnancy wearable, we aggregated the richest physiological dataset in the world linked to birth outcomes both in high-risk and low-risk moms. These data include clinical-grade physiological data on maternal and fetal health and real-world evidence on birth outcomes covering ~10k pregnancies. Our first digital biomarker for (preterm) labor detection has been clinically validated with results presented at the Society for Maternal-Fetal Medicine and World Congress for Maternal-Fetal Neonatal Medicine.

 

Grants and Awards

We have been recognized for our revolutionary vision and potential to impact lives globally, most recently receiving innovation awards and grants from Johnson & Johnson’s First 1000 Days Quick Fire Challenge, Fast Company World Changing Ideas, Maternal and Child Health Bureau, National Science Foundation, and the European Commission Horizon 2020 Initiative.

Learn more

Partners

CHU de Liege

Interested in learning more or partnering?

Get in touch to learn more or to inquire about collaborating. We look forward to hearing from you!